Abstract
simultaneous or sequential treatment of liver metastases of colon cancer? experience in 76 patients Background: Synchronous liver metastases of colon cancer can be managed with sequential or si multaneous surgical management of the primary tumor and the metastases. aim: To compare the evolution of patients whose liver metastases were treated sequentially or simultaneously. Material and Methods: Retrospective analysis of 76 patients aged 63 ± 11 years (67% males). In 25, metastases were managed simultaneously and in 51 there were treated sequentially after a period of chemotherapy. All interventions were performed by the same surgeon. results: Patients treated sequentially had a higher number of metastases and more lymph nodes involved than their counterparts treated simultaneously. The overall resectability index was 78%. Eighteen major and 28 minor hepatic resections were carried out. Significantly more major resections were carried out in the sequential treatment group. Mean hospital stay was 11 days and 20% of patients had complications, with no differences between groups. Survival at one, three and five years was 75, 45 and 36% in the simultaneous treatment and 76, 49 and 29% in the sequential treatment group (with no significant di fferences between groups). conclusions: In this group of patients no differences in complications or survival were observed when liver metastases were treated simultaneously or sequentially. However groups were not homogeneous.
Highlights
Synchronous liver metastases of colon cancer can be managed with sequential or simultaneous surgical management of the primary tumor and the metastases
All interventions were performed by the same surgeon
Patients treated sequentially had a higher number of metastases and more lymph nodes involved than their counterparts treated simultaneously
Summary
METÁSTASIS HEPÁTICAS DE ORIGEN COLOrRECTAL SINCRÓNICAS: ¿INTERVENCIÓN SIMULTÁNEA O SECUENCIAL?*. Drs Beatriz Pérez-Cabrera[1], Antonio Palomeque-Jiménez[1], Patricia Navarro-Sánchez[2], Amanda Rocío González-Ramírez[3], Francisco Navarro-Freire[1].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have